• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

远红外线辐射可缓解代谢功能障碍相关脂肪性肝病中的脂肪性肝炎和肝纤维化。

Far-infrared radiation alleviates steatohepatitis and fibrosis in metabolic dysfunction-associated fatty liver disease.

机构信息

Department of Dermatology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, China.

Chen Hongduo Academician Workstation, Shaoxing Central Hospital, Shaoxing, China.

出版信息

Sci Rep. 2024 Aug 20;14(1):19292. doi: 10.1038/s41598-024-69053-8.

DOI:10.1038/s41598-024-69053-8
PMID:39164313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11336198/
Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a disease that causes an abnormal accumulation of fat in the liver, triggering inflammation and fibrosis, the mechanism of which is not fully understood and for which there is a lack of specific drug therapy. Far-infrared radiation (FIR) has demonstrated evident therapeutic efficacy across various diseases, and novel nanomaterial graphene patches can emit it through electric heating. This study aimed to investigate the potential protective effects of FIR against MAFLD. Mice were fed with a MCD diet to mimic MAFLD progression, and histopathology analysis, biochemical analysis, RT-qPCR, and Western blotting analysis were performed to assess the effect of FIR on MAFLD in vivo. The effect of FIR treatment on MAFLD in vitro was investigated by biochemical analysis and gene expression profiling of hepatocytes. Mice subjected to the MCD diet and treated with FIR exhibited reduced hepatic lipid deposition, inflammation, fibrosis and liver damage. The therapeutic effect exerted by FIR in mice may be caused by the enhancement of AMPK phosphorylation and inhibition of the TGFβ1-SMAD2/3 pathway. Besides, FIR intervention alleviated MAFLD in hepatocytes in vitro and the results were verified by gene expression profiling. Our results revealed a promising potential of FIR as a novel therapeutic approach for MAFLD.

摘要

代谢相关脂肪性肝病(MAFLD)是一种导致肝脏脂肪异常堆积,引发炎症和纤维化的疾病,其发病机制尚未完全阐明,且缺乏特异性药物治疗。远红外辐射(FIR)在多种疾病中表现出明显的治疗效果,而新型纳米材料石墨烯贴片可以通过电热产生它。本研究旨在探讨 FIR 对 MAFLD 的潜在保护作用。通过给予 MCD 饮食来模拟 MAFLD 的进展,对小鼠进行组织病理学分析、生化分析、RT-qPCR 和 Western blot 分析,以评估 FIR 对体内 MAFLD 的影响。通过生化分析和肝细胞基因表达谱分析研究了 FIR 治疗对 MAFLD 的体外作用。接受 MCD 饮食和 FIR 治疗的小鼠肝脏脂质沉积、炎症、纤维化和肝损伤减少。FIR 在小鼠中发挥的治疗作用可能是通过增强 AMPK 磷酸化和抑制 TGFβ1-SMAD2/3 通路引起的。此外,FIR 干预减轻了体外 MAFLD ,并且通过基因表达谱得到了验证。我们的研究结果揭示了 FIR 作为 MAFLD 新型治疗方法的潜在应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5bc/11336198/95d4e85fab36/41598_2024_69053_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5bc/11336198/48853f0bc226/41598_2024_69053_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5bc/11336198/c8fc50a9b2f2/41598_2024_69053_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5bc/11336198/91ed70e8a236/41598_2024_69053_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5bc/11336198/95d4e85fab36/41598_2024_69053_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5bc/11336198/48853f0bc226/41598_2024_69053_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5bc/11336198/c8fc50a9b2f2/41598_2024_69053_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5bc/11336198/91ed70e8a236/41598_2024_69053_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5bc/11336198/95d4e85fab36/41598_2024_69053_Fig4_HTML.jpg

相似文献

1
Far-infrared radiation alleviates steatohepatitis and fibrosis in metabolic dysfunction-associated fatty liver disease.远红外线辐射可缓解代谢功能障碍相关脂肪性肝病中的脂肪性肝炎和肝纤维化。
Sci Rep. 2024 Aug 20;14(1):19292. doi: 10.1038/s41598-024-69053-8.
2
Herbal mixture of Platycodon grandiflorum, Cinnamomum cassia, and Asiasarum sieboldii extracts protects against NASH progression via regulation of hepatic steatosis, inflammation, and apoptosis.桔梗、肉桂和细辛提取物的草药混合物通过调节肝脏脂肪变性、炎症和细胞凋亡来预防非酒精性脂肪性肝炎的进展。
Phytomedicine. 2025 Jul 14;145:157077. doi: 10.1016/j.phymed.2025.157077.
3
Therapeutic effects of adipose tissue-derived mesenchymal stem cells on ER stress in a murine model of metabolic dysfunction-associated steatohepatitis: an in vivo and in vitro study.脂肪组织来源的间充质干细胞对代谢功能障碍相关脂肪性肝炎小鼠模型内质网应激的治疗作用:一项体内和体外研究
Stem Cell Res Ther. 2025 Jul 6;16(1):349. doi: 10.1186/s13287-025-04482-4.
4
ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH.ACMSD抑制可纠正代谢相关脂肪性肝病/非酒精性脂肪性肝炎中的纤维化、炎症和DNA损伤。
J Hepatol. 2025 Feb;82(2):174-188. doi: 10.1016/j.jhep.2024.08.009. Epub 2024 Aug 22.
5
Hydronidone Alleviates Metabolic Dysfunction-Associated Fatty Liver Disease by Inhibiting CD36 Expression.氢醌通过抑制CD36表达减轻代谢功能障碍相关脂肪性肝病
FASEB J. 2025 Aug 15;39(15):e70800. doi: 10.1096/fj.202501007R.
6
Cinnabarinic acid protects against metabolic dysfunction-associated steatohepatitis by activating aryl hydrocarbon receptor-dependent AMPK signaling.朱红酸通过激活芳烃受体依赖性AMPK信号通路预防代谢功能障碍相关脂肪性肝炎。
Am J Physiol Gastrointest Liver Physiol. 2025 Apr 1;328(4):G433-G447. doi: 10.1152/ajpgi.00337.2024. Epub 2025 Mar 10.
7
Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.评估瞬时弹性成像技术在诊断 MAFLD 中的应用,以及袖状胃切除术对中国人 MAFLD 的早期影响。
Int J Surg. 2024 Apr 1;110(4):2044-2054. doi: 10.1097/JS9.0000000000001078.
8
Buddleoside alleviates nonalcoholic steatohepatitis by targeting the AMPK-TFEB signaling pathway.毛蕊花糖苷通过靶向AMPK-TFEB信号通路减轻非酒精性脂肪性肝炎。
Autophagy. 2025 Jun;21(6):1316-1334. doi: 10.1080/15548627.2025.2466145. Epub 2025 Mar 16.
9
Oridonin Ameliorates Metabolic-Dysfunction-Associated Fatty Liver Disease by Inhibiting PANoptosis via Modulating SIRT2/NLRP3 Pathway.冬凌草甲素通过调节SIRT2/NLRP3通路抑制PAN凋亡来改善代谢功能障碍相关脂肪性肝病。
Phytother Res. 2025 Aug 6. doi: 10.1002/ptr.70055.
10
Hepatocellular CMPK2 promotes the development of metabolic dysfunction-associated steatohepatitis.肝细胞CMPK2促进代谢功能障碍相关脂肪性肝炎的发展。
J Hepatol. 2025 Jan 22. doi: 10.1016/j.jhep.2025.01.008.

引用本文的文献

1
Therapeutic Potential of Infrared and Related Light Therapies in Metabolic Diseases.红外线及相关光疗法在代谢性疾病中的治疗潜力
Int J Mol Sci. 2025 May 27;26(11):5134. doi: 10.3390/ijms26115134.

本文引用的文献

1
Short-term tamoxifen administration improves hepatic steatosis and glucose intolerance through JNK/MAPK in mice.短期他莫昔芬给药通过 JNK/MAPK 改善小鼠肝脂肪变性和葡萄糖不耐受。
Signal Transduct Target Ther. 2023 Mar 3;8(1):94. doi: 10.1038/s41392-022-01299-y.
2
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).非酒精性脂肪性肝病/脂肪性肝炎(NAFL/NASH)中的靶向治疗和新型信号通路。
Signal Transduct Target Ther. 2022 Aug 13;7(1):287. doi: 10.1038/s41392-022-01119-3.
3
Association between hepatic steatosis and fibrosis indices and dietary habits, physical activity, and quality of life.
肝脂肪变性与纤维化指标、饮食习惯、身体活动及生活质量之间的关联
Arab J Gastroenterol. 2022 Nov;23(4):277-287. doi: 10.1016/j.ajg.2022.05.006. Epub 2022 Aug 1.
4
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
Lancet. 2021 Jun 5;397(10290):2212-2224. doi: 10.1016/S0140-6736(20)32511-3. Epub 2021 Apr 21.
5
Coenzyme Q Supplementation Improves Adipokine Levels and Alleviates Inflammation and Lipid Peroxidation in Conditions of Metabolic Syndrome: A Meta-Analysis of Randomized Controlled Trials.辅酶 Q 补充剂可改善代谢综合征患者的脂肪因子水平,减轻炎症和脂质过氧化:一项随机对照试验的荟萃分析。
Int J Mol Sci. 2020 May 4;21(9):3247. doi: 10.3390/ijms21093247.
6
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.2012 年至 2017 年全球慢性肝病负担的变化:非酒精性脂肪性肝病的影响日益增加。
Hepatology. 2020 Nov;72(5):1605-1616. doi: 10.1002/hep.31173. Epub 2020 Oct 27.
7
Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice.柚皮苷通过下调 NLRP3/NF-κB 通路减轻小鼠非酒精性脂肪肝病。
Br J Pharmacol. 2020 Apr;177(8):1806-1821. doi: 10.1111/bph.14938. Epub 2020 Jan 30.
8
Curcumin Ameliorates Nonalcoholic Fatty Liver Disease through Inhibition of -GlcNAcylation.姜黄素通过抑制 -GlcNAc 酰化作用改善非酒精性脂肪性肝病。
Nutrients. 2019 Nov 8;11(11):2702. doi: 10.3390/nu11112702.
9
Hepatic Metabolic Derangements Triggered by Hyperthermia: An In Vitro Metabolomic Study.热疗引发的肝脏代谢紊乱:一项体外代谢组学研究
Metabolites. 2019 Oct 15;9(10):228. doi: 10.3390/metabo9100228.
10
Molecular pathways of nonalcoholic fatty liver disease development and progression.非酒精性脂肪性肝病发生和进展的分子途径。
Cell Mol Life Sci. 2019 Jan;76(1):99-128. doi: 10.1007/s00018-018-2947-0. Epub 2018 Oct 20.